Matthew Hook
Matthew Hook has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Grace Lowor
University of Florida
2 shared publications - Julieth Gomez
J. Crayton Pruitt Family Department of Biomedical Engineering
2 shared publications - Kelly D. Foote
University of Florida
2 shared publications - Michael Scott Okun
University of Florida
2 shared publications - William Tvenstrup
J. Crayton Pruitt Family Department of Biomedical Engineering
2 shared publications Aysegul Gunduz
University of Florida
1 shared publication
Latest Publications
- Open Access
- 21 September 2026
- Published by University of Florida George A Smathers Libraries in UF Journal of Undergraduate Research
- Vol. 28
Modeling DBS Tolerability in Tourette Syndrome: Unilateral and Bilateral Effects Characterization
Deep Brain Stimulation (DBS) can reduce symptoms in medically refractory Tourette syndrome (TS), but programming optimization is constrained by stimulation-induced side-effects. This study uses thresholding data from 8 participants with TS to model DBS tolerability across targets centromedian thalamus (CM); anterior globus pallidus internus (aGPi), hemispheres, and contact levels, to quantify unilateral and bilateral side-effects. Laterality was evaluated in a unilateral (n=8) and a bilateral (n=4) subset using stimulation-threshold comparisons. Stimulation amplitudes increased incrementally until the first side-effect, and trials without side-effects were treated as ‘censored’ during thresholding. This study modeled unilateral amplitude-to-side-effect using target, hemisphere, and 4-contact levels as fixed effects and a gamma frailty term to capture subject heterogeneity. The aGPi showed higher relative tolerability than the CM (hazard ratio = 0.6), with contact-level dependence and substantial between-subject variability. Directional mode testing was heavily censored at the 2-mA ceiling, preventing robust modeling. Matched analysis indicated lower bilateral thresholds, particularly at deeper contacts, with wide 95% confidence intervals. These findings support subject-specific tolerability profiling to inform more data-driven DBS programming practices and motivate larger cohort studies.
- 21 September 2026
- Published by University of Florida George A Smathers Libraries in UF Journal of Undergraduate Research
- Vol. 28
Open AccessModeling DBS Tolerability in Tourette Syndrome: Unilateral and Bilateral Effects Characterization
Deep Brain Stimulation (DBS) can reduce symptoms in medically refractory Tourette syndrome (TS), but programming optimization is constrained by stimulation-induced side-effects. This study uses thresholding data from 8 participants with TS to model DBS tolerability across targets centromedian thalamus (CM); anterior globus pallidus internus (aGPi), hemispheres, and contact levels, to quantify unilateral and bilateral side-effects. Laterality was evaluated in a unilateral (n=8) and a bilateral (n=4) subset using stimulation-threshold comparisons. Stimulation amplitudes increased incrementally until the first side-effect, and trials without side-effects were treated as ‘censored’ during thresholding. This study modeled unilateral amplitude-to-side-effect using target, hemisphere, and 4-contact levels as fixed effects and a gamma frailty term to capture subject heterogeneity. The aGPi showed higher relative tolerability than the CM (hazard ratio = 0.6), with contact-level dependence and substantial between-subject variability. Directional mode testing was heavily censored at the 2-mA ceiling, preventing robust modeling. Matched analysis indicated lower bilateral thresholds, particularly at deeper contacts, with wide 95% confidence intervals. These findings support subject-specific tolerability profiling to inform more data-driven DBS programming practices and motivate larger cohort studies.
- Open Access
- 5 November 2025
- Published by University of Florida George A Smathers Libraries in UF Journal of Undergraduate Research
- Vol. 27
Evaluating Deep Brain Stimulation Tolerability in Tourette Syndrome
Deep brain stimulation (DBS) is an emerging treatment for individuals with Tourette Syndrome (TS), a neuropsychiatric disorder characterized by motor and vocal tics. This study investigated the safety and tolerability of unilateral DBS in six individuals with medically refractory TS. Quantitative threshold amplitudes and qualitative side effects were evaluated during controlled DBS modulation in the centromedian nucleus (CM) of the thalamus and the anterior internal segment of the globus pallidum (aGPi). Key findings suggest that patients are more tolerable to aGPi stimulation (2.2 ± 0.0 mA) and stimulation in ring mode electrode configuration (3.3 ± 3.2 mA). A significant statistical interaction (p = 0.013) was found between the aGPi and CM, suggesting an electrophysiological or anatomical connection between them. Paresthesia (46.85%) was the frequently occurring adverse effect experienced by all patients regardless of stimulation modulation. Insights gained could refine stimulation parameters, enhance therapeutic efficacy, and reduce side effects, contributing to personalized treatment strategies for TS.
- 5 November 2025
- Published by University of Florida George A Smathers Libraries in UF Journal of Undergraduate Research
- Vol. 27
Open AccessEvaluating Deep Brain Stimulation Tolerability in Tourette Syndrome
Deep brain stimulation (DBS) is an emerging treatment for individuals with Tourette Syndrome (TS), a neuropsychiatric disorder characterized by motor and vocal tics. This study investigated the safety and tolerability of unilateral DBS in six individuals with medically refractory TS. Quantitative threshold amplitudes and qualitative side effects were evaluated during controlled DBS modulation in the centromedian nucleus (CM) of the thalamus and the anterior internal segment of the globus pallidum (aGPi). Key findings suggest that patients are more tolerable to aGPi stimulation (2.2 ± 0.0 mA) and stimulation in ring mode electrode configuration (3.3 ± 3.2 mA). A significant statistical interaction (p = 0.013) was found between the aGPi and CM, suggesting an electrophysiological or anatomical connection between them. Paresthesia (46.85%) was the frequently occurring adverse effect experienced by all patients regardless of stimulation modulation. Insights gained could refine stimulation parameters, enhance therapeutic efficacy, and reduce side effects, contributing to personalized treatment strategies for TS.